Immuno-related endocrinopathy in patients treated with immune checkpoint inhibitors

Recently immune checkpoint inhibitors amazingly changed the landscape of cancer therapy worldwide. The number of immune checkpoint molecules in clinical practice is constantly increasing. There are some monoclonal antibodies recently registered in the Russian Federation: anti-PD1 antibodies (nivolum...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: D. I. Yudin, K. K. Laktionov, K. A. Sarantseva, O. I. Borisova, V. V. Breder, E. V. Reutova, M. F. Beloyartseva, S. Yu. Kruteleva, I. A. Dzhanyan
格式: Artigo
語言:Russo
出版: Remedium Group LLC 2020-07-01
叢編:Медицинский совет
主題:
immune-related endocrinopathy
immunotherapy
checkpoint inhibitors
anti-ctla-4
anti-pd-1/pd-l1
在線閱讀:https://www.med-sovet.pro/jour/article/view/5697
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍